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Background: Osteoarthritis is the most common chronic joint disease. In the absence of an effective medical
treatment and due to the chronic nature of this condition, an osteoarthritis medical diagnosis may finally result
in decreased health-related quality of life. Therefore, the aim of this study was to measure the impact of the
osteoarthritis medical labelling on physical and mental health-related quality of life.
Methods: Subjects (n = 1132, 58.7% women) were approached as participants of an urban population-based cohort
(EPIPorto). Self-reported information on previous diagnosis of knee, hip or hand osteoarthritis was obtained and
rheumatologists established knee, hip or hand osteoarthritis clinical diagnosis in symptomatic individuals. Physical
and mental dimensions of health-related quality of life were evaluated using the self-administered Medical
Outcomes Study: 36-Item Short Form Survey. Crude and adjusted linear regression coefficients (beta) and the
corresponding 95% confidence intervals (95% CI) were computed to estimate the associations between being
labelled as an osteoarthritis case and health-related quality of life.
Results: Regardless of disease medical labelling, individuals with osteoarthritis scored significantly lower physical
health-related quality of life when compared to those without joint disease (kneeunexposed: beta = −5.3, 95%
CI: −7.6, −3.1; kneeexposed: beta = −6.0, 95% CI: −8.4, −3.7; hipunexposed: beta = −6.0, 95% CI: −9.8, −2.3; hipexposed:
beta = −11.0, 95% CI: −15.6, −6.4; handunexposed: beta = −4.3, 95% CI: −6.5, −2.0; handexposed: beta = −4.3, 95%
CI: −6.6, −2.1). The same was not observed regarding mental health-related quality of life. Among subjects with
clinically confirmed osteoarthritis, the medical labelling of this joint disease was not significantly associated to
health-related quality of life.
Conclusions: The labelling of knee, hip and hand osteoarthritis diagnosis may not add specific benefit to
osteoarthritis patients in terms of its capability to improve health-related quality of life.
Keywords: Osteoarthritis, Quality of life, DiagnosisBackground
Musculoskeletal conditions are a major contributor to
the burden of disease worldwide [1]. These disorders were
responsible for 6.8% of the global disability-adjusted life
years worldwide [2], with osteoarthritis representing the
single most important condition [3]. Due to its high inci-
dence and low case-fatality, osteoarthritis affects a sub-
stantial part of the population [4]. Even though the impact
of osteoarthritis on individuals (impairment of daily activ-
ities and professional life) and society is undeniable [5-9],
doubt persists about the usefulness of early diagnosis in* Correspondence: slourenco@med.up.pt
1Institute of Public Health of the University of Porto, Rua das Taipas, 135-139,
4050-600 Porto, Portugal
Full list of author information is available at the end of the article
© 2014 Lourenço et al.; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.modifying prognosis and patient general well-being, since
most non-invasive management approaches show low effi-
cacy or poor adherence [10,11].
Current guidelines emphasize health-related quality of
life as a priority in healthcare services, particularly as
part of chronic disease management [12]. Quality of life
is a personal and autonomous concept that is influenced
by social and emotional contexts and not simply explained
by the absence of physical symptoms or disease [13,14].
Accordingly, it is plausible that the impact of knowing the
name and the expected consequences of a disease may
contribute to modify the well-being and welfare judg-
ments and, consequently, the overall perceived health-
related quality of life.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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gested that diagnostic labelling affects the self-perception
of physical and mental health status regardless of objective
pathophysiological changes or previous knowledge about
the presence of a certain condition without symptom his-
tory [15-18]. The medical labelling of a long-standing
chronic disease with suboptimal management effective-
ness, as it is expected for osteoarthritis, might impair
health-related quality of life without providing the add-
itional benefit to offset it [19]. However, up to the present,
the effect of osteoarthritis medical labelling on health-
related quality of life remains unknown.
Therefore, using data from a community-based sample
of adults, we compared the physical and mental health-
related quality of life between previously diagnosed (la-
belled) and undiagnosed (not labelled) osteoarthritis




The EPIPorto study is a population-based cohort of adult
inhabitants of the city of Porto (Portugal). Recruitment
and baseline data collection occurred between 1999 and
2003 and have already been described elsewhere [20].
Briefly, subjects were selected by random digit dialling,
considering households as the sampling frame. When a
household was identified all residents were described by
sex and age. One of those residents (aged 18 or older) was
randomly selected as the respondent. If the invited resi-
dent refused, there was no replacement. A visit to the
Medical School was scheduled by telephone, according to
the convenience of the participants. Baseline participation
proportion was 70% (n = 2485). This investigation was
based on cross-sectional data collected at an evaluation of
the EPIPorto study carried out between 2005 and 2008
and included 1132 (58.7% women) adults with complete
information for all variables of interest. Individuals in-
volved in this study were more frequently women, were
on average younger, were more educated, had lower body
mass index and scored higher in the physical dimension
of health-related quality of life when compared with the
remaining cohort participants at baseline.
Data collection
Knee, hip and hand osteoarthritis medical labelling (exposure)
Subjects were classified according to the following sources
of information: a) self-reported osteoarthritis; and b) clin-
ical osteoarthritis diagnosis at the moment of evaluation.
a) Self-reported osteoarthritis (labelling)
Before asking individuals about joint pain or schedul-
ing clinical assessment, participants were asked if theyhad ever had a medical diagnosis of osteoarthritis (“has a
doctor ever diagnosed you with knee/hip/hand arthritis?”).
b) Clinical diagnosis of osteoarthritis at the moment of
evaluation
All subjects were asked if they had ever felt pain in the
knee(s), hip(s) or hand(s) not resulting from direct trauma.
Those who answered affirmatively were asked a further
set of questions about pain and were classified as having
clinically relevant joint pain if they filled one or more of
the following criteria: a) at least one medical appointment
with exams or medication prescribed in the previous year
due to that pain; b) three or more pain episodes in the
previous year with a perceived mean intensity equal to or
over 60 millimetres (severe pain) in a visual analogue
scale; c) one or more pain episodes lasting over one week
in the previous six months; or d) one or more pain epi-
sodes in the previous month with a perceived mean inten-
sity equal to or over 60 millimetres (severe pain) in a
visual analogue scale. This algorithm was previously vali-
dated to our sample and has shown to be accurate for
screening osteoarthritis of the knee, hip and hand [21].
Those who filled out at least one of those criteria were
selected for evaluation by a rheumatologist. After the
clinical assessment, participants were classified as having
or not having knee, hip or hand osteoarthritis according
to the American College of Rheumatology Clinical Clas-
sification Criteria for Osteoarthritis of the knee [22], hip
[23] and hand [24].
Participants were then classified into one of the fol-
lowing three groups:
1) Subjects with clinical osteoarthritis but without
previous disease label
Subjects who were classified as having clinical osteo-
arthritis in the rheumatologic assessment and who were
previously unaware of the disease were considered “un-
exposed” to the diagnosis labelling.
2) Subjects with clinical osteoarthritis and with a
previous disease label
Participants who were classified in the clinical assessment
as having osteoarthritis and who had previously reported
that they had a diagnosis of osteoarthritis were considered
“exposed” due to their awareness (medical labelling).
3) Subjects without evidence of significant joint pain or
disease
Since the previous groups consist of individuals with
clinically relevant disease, we identified the need to obtain
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target population. For that we used the group composed
by all subjects who did not fill at least one of the above-
mentioned criteria for significant joint pain or who re-
ported significant pain but were considered free from clin-
ically significant disease by the rheumatologist.
Physical and mental dimensions of health-related quality of
life (outcomes)
The physical and mental dimensions of health-related
quality of life were assessed using the self-administered
Medical Outcomes Study 36-Item Short Form Survey
(SF-36), which was previously validated for the Portuguese
population [25]. All participants answered the SF-36 prior
to awareness of their eligibility for the rheumatologist
appointment.
The construction of the physical and mental health-
related quality of life dimensions was divided in three
main steps. In the first step, the eight sub-dimensions of
the self-administered SF-36 Portuguese version were nor-
malized (z-scores: mean = 0; standard-deviation = 1) using
the means and the standard-deviations obtained in the
population of Porto in each sub-dimension of SF-36. In the
second step, the eight sub-dimensions were aggregated
using the coefficients obtained by principal components
analysis. Finally, in the third step, the two SF-36 main com-
ponents (physical and mental health-related quality of life)
were normalized considering mean = 50 and standard-
deviation = 10. In both physical and mental dimensions of
health-related quality of life, higher values correspond to
better levels of functioning and well-being [4,25].
Potential confounders
Individual and clinical characteristics that might be caus-
ally related both to osteoarthritis labelling and to health-
related quality of life were collected.
Demographic and socioeconomic information was col-
lected by face-to-face interviews and included data on
sex, age (65 or less; more than 65 years of age) and educa-
tion (12 or less; more than 12 completed schooling years).
Participants were asked whether in the previous month
they had felt knee, hip or hand pain (“during the past
month did you experience knee/hip/hand pain?”). Those
reporting knee, hip or hand pain in the preceding month
were asked about the intensity of knee, hip and hand pain
using a visual analogue scale (range: 0–100 millimetres).
Subjects were then grouped according to the severity of
pain as follows: 40 or less (no pain to mild pain); more
than 40 millimetres (moderate to severe pain).
Data on a wide spectrum of self-reported comorbidities
(cardiovascular, respiratory, endocrine, cancer, and rheum-
atic diseases other than osteoarthritis) were collected. Sub-
jects were grouped as not having any comorbid condition
or as having at least one comorbid condition.Weight and height were obtained while the individuals
stood barefoot in light indoor clothing. Weight was mea-
sured to the nearest tenth of kilogram (Tanita® bioimpe-
dance scales) and height was measured in centimetres,
to the nearest tenth with a portable stadiometer (Seca®).
Body mass index was calculated dividing the weight (ki-
lograms) by the squared height (metres) and participants
were grouped as follows: less than 30 (not obese); 30 or
more kg/m2 (obese).
Data analysis
For each anatomical site (knee, hip or hand), individuals
were grouped according to the following criteria: a) sub-
jects with clinical osteoarthritis but without previous
disease label; b) subjects with clinical osteoarthritis and
with a previous disease label; and c) subjects without
evidence of significant joint pain or disease.
Participants’ characteristics are presented according to
clinically-ascertained and self-reported osteoarthritis in
each anatomical site (knee, hip and hand). All categorical
variables are presented as counts and proportions and
normally distributed continuous variables are presented
as means and standard-deviations. Proportions were com-
pared using chi-square tests and continuous variables were
compared using Student’s t-test or the One-way Analysis
of Variance (ANOVA).
Crude and adjusted (for sex, age, education, body mass
index, intensity of pain and clinical comorbidities) linear
regression coefficients (β) and the corresponding 95%
confidence intervals (95% CI) were computed to esti-
mate the associations between osteoarthritis medical la-
belling (in the knee, hip and hand) and physical and
mental health-related quality of life.
Statistical analyses were performed using Stata® version
11.2 for Windows (Stata Corp. LP, College Station, Texas,
USA).
Ethics
The EPIPorto study was approved by the Ethics Com-
mittee of Hospital of São João and the University of
Porto Medical School (Porto). Written informed consent
in accordance with the 1964 Declaration of Helsinki (and
its later amendments) was obtained from all participants.
Results
Osteoarthritis labelling (knee, hip or hand)
Table 1 summarizes the characteristics of participants
according to clinical evidence and labelling of osteoarth-
ritis in the knee, hip or hand. Among individuals with
clinically confirmed osteoarthritis, patients with previous
disease labelling were more frequently women, had higher
body mass index and reported more severe stages of joint-
related pain when compared to those without previous
disease labelling.
Table 1 Participants’ characteristics by anatomical site (knee, hip and hand) and according to clinical evidence and
labelling of osteoarthritis
Anatomical site Total Absence of joint
disease




n (%) n (%) n (%) n (%) p* p†
Knee (n = 1040) 906 (87.1) 58 (5.6) 76 (7.3)
Sex
Female 588 (56.5) 486 (53.6) 42 (72.4) 60 (79.0) p < 0.001 0.379
Male 452 (43.5) 420 (46.4) 16 (27.6) 16 (21.1)
Age
≤65 years 778 (74.8) 722 (79.7) 28 (48.3) 28 (36.8) p < 0.001 0.145
>65 years 262 (25.2) 184 (20.3) 30 (51.7) 48 (63.2)
Education
≤12 years 693 (66.6) 572 (63.1) 51 (87.9) 70 (92.1) p < 0.001 0.419
>12 years 347 (33.4) 334 (36.9) 7 (12.1) 6 (7.9)
BMI
<30 kg/m2 830 (79.8) 749 (82.7) 42 (72.4) 39 (51.3) p < 0.001 0.013
≥30 kg/m2 210 (20.2) 157 (17.3) 16 (27.6) 37 (48.7)
Intensity of pain
≤40 mm 922 (88.6) 868 (95.8) 33 (56.9) 21 (27.6) p < 0.001 0.001
>40 mm 118 (11.4) 38 (4.2) 25 (43.1) 55 (72.4)
Comorbidities
No comorbidities 330 (31.7) 314 (34.7) 8 (13.8) 8 (10.5) p < 0.001 0.563
At least one comorbidity 710 (68.3) 592 (65.3) 50 (86.2) 68 (89.5)
Hip (n = 941) 906 (96.3) 20 (2.1) 15 (1.6)
Sex
Female 510 (54.2) 486 (53.6) 11 (55.0) 13 (86.7) 0.039 0.046
Male 431 (45.8) 420 (46.4) 9 (45.0) 2 (13.3)
Age
≤65 years 735 (78.1) 722 (79.7) 9 (45.0) 11 (73.3) p < 0.001 0.094
>65 years 206 (21.9) 184 (20.3) 11 (55.0) 4 (26.7)
Education
≤12 years 600 (66.4) 572 (63.1) 16 (80.0) 12 (80.0) 0.126 0.999
>12 years 341 (36.2) 334 (36.9) 4 (20.0) 3 (20.0)
BMI
<30 kg/m2 768 (81.6) 749 (82.7) 16 (80.0) 3 (20.0) p < 0.001 p < 0.001
≥30 kg/m2 173 (18.4) 157 (17.3) 4 (20.0) 12 (80.0)
Intensity of pain
≤40 mm 897 (95.3) 883 (97.5) 10 (50.0) 4 (26.7) p < 0.001 0.163
>40 mm 44 (4.7) 23 (2.5) 10 (50.0) 11 (73.3)
Comorbidities
No comorbidities 321 (34.1) 314 (34.7) 6 (30.0) 1 (6.7) 0.071 0.088
At least one comorbidity 620 (65.9) 592 (65.3) 14 (70.0) 14 (93.3)
Hand (n = 1040) 906 (87.1) 56 (5.4) 78 (7.5)
Sex
Female 601 (57.8) 486 (53.6) 43 (76.8) 72 (92.3) p < 0.001 0.011
Male 439 (42.7) 420 (46.4) 13 (23.2) 6 (7.7)
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Table 1 Participants’ characteristics by anatomical site (knee, hip and hand) and according to clinical evidence and
labelling of osteoarthritis (Continued)
Age
≤65 years 780 (75.0) 722 (79.7) 23 (41.2) 35 (44.9) p < 0.001 0.502
>65 years 260 (25.0) 184 (20.3) 33 (58.9) 43 (55.1)
Education
≤12 years 691 (66.4) 572 (63.1) 47 (83.9) 72 (92.3) p < 0.001 0.129
>12 years 349 (33.6) 334 (36.9) 9 (16.1) 6 (7.7)
BMI
<30 kg/m2 836 (80.4) 749 (82.7) 39 (69.6) 48 (61.5) p < 0.001 0.332
≥30 kg/m2 204 (19.6) 157 (17.3) 17 (30.4) 30 (38.5)
Intensity of pain
≤40 mm 945 (90.9) 874 (96.5) 40 (71.4) 31 (39.7) p < 0.001 p < 0.001
>40 mm 95 (9.1) 32 (3.5) 16 (28.6) 47 (60.3)
Clinical comorbidities
No comorbidities 334 (32.1) 314 (34.7) 9 (16.1) 11 (14.1) p < 0.001 0.752
At least one comorbidity 706 (67.9) 592 (65.3) 47 (83.9) 67 (85.9)
Legend: OA: Osteoarthritis; BMI: Body mass index; kg: Kilogram; m: Metres; mm: Millimetres.
*Comparison between the following groups: absence of joint disease vs. with OA but not labelled with OA vs. with OA and labelled with OA.
†Comparison between the following groups: with OA but not labelled with OA vs. with OA and labelled with OA.
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of life
Table 2 presents crude and adjusted linear regression co-
efficients to quantify the associations between the osteo-
arthritis medical labelling (knee, hip and hand) and the
physical and mental dimensions of health-related quality
of life, taking into account two different reference cat-
egories: a) individuals with no evidence of significant
chronic joint pain; and b) individuals with osteoarthritis
but not previously aware of their condition.Physical dimension of health-related quality of life
Regardless of disease labelling, subjects who were clinic-
ally diagnosed with knee, hip or hand osteoarthritis per-
ceived lower physical health-related quality of life when
compared to those without osteoarthritis. These associ-
ations remained statistically significant after adjustment
for sex, age, education, body mass index, intensity of
pain and clinical comorbidities (kneeunexposed: β = −5.3,
95% CI: −7.6, −3.1; kneeexposed: β = −6.0, 95% CI: −8.4, −3.7;
hipunexposed: β = −6.0, 95% CI: −9.8, −2.3; hipexposed:
β = −11.0, 95% CI: −15.6, −6.4; handunexposed: β = −4.3, 95%
CI: −6.5, −2.0; handexposed: β = −4.3, 95% CI: −6.6, −2.1).
Among individuals with clinically confirmed osteo-
arthritis, no significant associations were found between
the awareness of having knee, hip or hand osteoarthritis
and the physical dimension of health-related quality of
life, even after adjustment for confounders.Mental dimension of health-related quality of life
After adjustment for sex, age, education, body mass index,
intensity of pain and clinical comorbidities, we observed
that osteoarthritis presence (medically labelled or not) did
not change significantly mental health-related quality of
life when the comparison group was composed by indi-
viduals without joint disease (kneeunexposed: β = −2.1,
95% CI: −4.8, 0.6; kneeexposed: β = −3.5, 95% CI: −6.3, −0.7;
hipunexposed: β = −1.2, 95% CI: −5.8, 3.3; hipexposed: β = −5.0,
95% CI: −10.6, 0.6; handunexposed: β = −0.5, 95% CI: −3.3,
2.3; handexposed: β = −2.3, 95% CI: −5.0, 0.4).
Among individuals with clinically confirmed joint dis-
ease, we did not observe any significant association be-
tween the labelling of knee, hip or hand osteoarthritis
and the mental dimension of health-related quality of
life, even after adjustment for confounders.
Discussion
Our findings suggest that, compared to individuals with
no evidence of significant chronic joint pain, osteoarth-
ritis significantly reduces physical health-related quality
of life regardless of its medical labelling. However, among
individuals with clinically confirmed disease, the labelling
of knee, hip or hand osteoarthritis did not play a major role
in physical or mental health-related quality of life scores.
Previous research has shown that osteoarthritis patients
frequently score lower in health-related quality of life
when compared to those without this condition [26-28].
Beyond the negative emotional impact of living with a
Table 2 Linear regression coefficients and the corresponding 95% confidence intervals for the associations between
the osteoarthritis medical labelling and the physical and mental dimensions of health-related quality of life in the
knee, hip and hand
Anatomical site Physical HRQOL Mental HRQOL









Absence of joint disease 52.8 (8.7) 0.148 Ref 1 Ref 1 50.5 (9.8) 0.658 Ref 1 Ref 1
With OA but not labelled
with OA
42.3 (10.4) −10.5 (−12.8, −8.1) −5.3 (−7.6, −3.1) 47.6 (10.5) −2.9 (−5.5, −0.3) −2.1 (−4.8, 0.6)
With OA and labelled
with OA
38.8 (8.4) −14.0 (−16.0, −11.9) −6.0 (−8.4, −3.7) 46.1 (10.2) −4.5 (−6.8, −2.1) −3.5 (−6.3, −0.7)
With OA but not labelled
with OA
42.3 (10.4) 0.034 Ref 2 Ref 2 47.6 (10.5) 0.393 Ref 2 Ref 2
With OA and labelled
with OA
38.8 (8.4) 3.5 (0.3, 6.7) 1.2 (−1.9, 4.3) 46.1 (10.2) 1.5 (−2.0, 5.1) 1.5 (−2.2, 5.2)
Hip
Absence of joint disease 52.8 (8.7) 0.538 Ref 1 Ref 1 50.5 (9.8) 0.125 Ref 1 Ref 1
With OA but not labelled
with OA
42.3 (9.1) −10.6 (−14.4, −6.7) −6.0 (−9.8, −2.3) 49.0 (12.3) −1.5 (−5.9, 2.9) −1.2 (−5.8, 3.3)
With OA and labelled
with OA
32.4 (7.0) −20.4 (−24.9, −16.0) −11.0 (−15.6, −6.4) 44.1 (12.6) −6.4 (−11.5, −1.4) −5.0 (−10.6, 0.6)
With OA but not labelled
with OA
42.3 (9.1) 0.001 Ref 2 Ref 2 49.0 (12.3) 0.253 Ref 2 Ref 2
With OA and labelled
with OA
32.4 (7.0) 9.9 (4.1, 15.6) 5.5 (−1.1, 12.1) 44.1 (12.6) 4.9 (−3.7, 13.6) 4.7 (−6.9, 16.2)
Hand
Absence of joint disease 52.8 (8.7) 0.325 Ref 1 Ref 1 50.5 (9.8) 0.169 Ref 1 Ref 1
With OA but not labelled
with OA
43.7 (9.3) −9.1 (−11.5, −6.7) −4.3 (−6.5, −2.0) 49.3 (10.7) −1.3 (−3.9, 1.4) −0.5 (−3.3, 2.3)
With OA and labelled
with OA
41.4 (9.8) −11.4 (−13.5, −9.4) −4.3 (−6.6, −2.1) 46.4 (11.2) −4.1 (−6.4, −1.8) −2.3 (−5.0, 0.4)
With OA but not labelled
with OA
43.7 (9.3) 0.172 Ref 2 Ref 2 49.3 (10.7) 0.144 Ref 2 Ref 2
With OA and labelled
with OA
41.4 (9.8) 2.3 (−1.0, 5.6) 0.0 (−3.1, 3.1) 46.4 (11.2) 2.8 (−1.0, 6.6) 1.2 (−2.8, 5.2)
Legend: HRQOL: Health-related quality of life; SD: Standard-deviation; β: linear regression coefficient; 95% CI: 95% Confidence interval; OA: Osteoarthritis.
*Adjusted for sex (female; male), age (<65; ≥65 years), education (≤12; >12 years), body mass index (<30; ≥30 kg/m2), intensity of pain (≤40; >40 millimetres) and
clinical comorbidities (no comorbidities; at least one comorbidity).
Ref 1: this reference group comprised individuals who were not diagnosed with osteoarthritis in any anatomical region in study.
Ref 2: this reference group comprised individuals who were diagnosed with osteoarthritis but were not previously labelled with this joint disease.
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crucial to the performance of daily activities [29,30], which
was underlined by our findings showing that a worse
physical health-related quality of life occurs when osteo-
arthritis is present (compared to those with no evidence of
osteoarthritis), independently of the joint considered.
Regarding the physical dimension of well-being, evi-
dence has been consistent in showing that disease label-
ling negatively influences quality of life [17,18,31]. Cancer
labelling has been particularly investigated, showing that
the awareness of disease presence and severity significantly
worsened the perception of health-related quality of life
[32-35]. Nevertheless, among individuals with clinicalconfirmed osteoarthritis, disease labelling did not sig-
nificantly interfere with health-related quality of life.
Diagnosis establishment is expected to positively change
the natural history of the condition, since it is expected
to guide clinical practice into a better treatment and
management of the disease. Osteoarthritis is a particular
case because the available conservative treatments have
insufficient effectiveness, and its surgical alternative (joint
replacement surgery) is usually restricted to more severe
cases of disease and has low acceptability in some settings
[36]. Comparatively to other chronic diseases, osteoarth-
ritis labelling may have lower potential to modify physical
health-related quality of life particularly because without
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diagnosis may exclusively contribute to the amplification
of the vigilance and concern about the joint disease-
related symptoms [37]. The fact that osteoarthritis has vir-
tually null case-fatality when compared to other condi-
tions such as cancer may also account for the negligible
effect we have found in this study.
In relation to mental health-related quality of life, we
did not observe a consistent effect of osteoarthritis
labelling on this dimension of well-being, whether the
reference group was composed by subjects without joint
disease or by osteoarthritis patients not previously
aware of the diagnosis. On the one hand, osteoarthritis
labelling might trigger negative cognitions and emotions
due to the awareness of living with a chronic disease
whose effectiveness of treatments is doubtful [38,39].
On the other hand, osteoarthritis labelling might have a
positive interpretation, i.e., better chronicity than fatal-
ity. The balance between these two opposite meanings
of osteoarthritis labelling is a probable explanation to the
absence of significant results regarding mental-health
related quality of life, even when the comparison group
was composed by subjects without clinically confirmed
joint disease.
Active case-finding of osteoarthritis, unlike clinical exam-
ination of unspecific complaints, implies the systematic
search for one disease by taking advantage of the contacts
of previously unaware individuals with the health care
services. In clinical practice there is little advantage in
searching for the presence of osteoarthritis in the absence
of joint pain [40], which is reasonable given that doubt per-
sists about the usefulness of early diagnosis and treatment
in modifying prognosis [11,19]. If an effective medical inter-
vention and management of the disease occurred after
osteoarthritis diagnosis, the presence of a previous medical
labelling should be associated to a significant improvement
of health-related quality of life, especially in its physical
dimension. However, as suggested by our findings, the
labelling of osteoarthritis seems not to provide any spe-
cific additional benefit regarding health-related quality
of life of patients.
To the best of our knowledge, this is the first study
looking at the effect of osteoarthritis medical labelling
on physical and mental health-related quality of life, using
as reference a group of subjects from the general popula-
tion without evidence of joint disease. This is a major
strength since baseline health-related quality of life may
depend on specific characteristics of the source population,
particularly in middle-aged individuals. Another major
strength of this study is that it provides an ample spectrum
of the disease severity because it was based on data col-
lected in a community-based sample. All participants were
assessed using the same protocol and were evaluated by a
single observer (rheumatologist) using the gold standardmethod for case ascertainment, which is also a relevant ad-
vantage of this research.
Nevertheless, some methodological issues need to be
addressed. Recall bias may reduce the validity of the
evocation of the information that was used to define
preceding label of osteoarthritis. The number of years
elapsed between knee, hip or hand osteoarthritis medical
labelling and the moment of evaluation of the EPIPorto
cohort was analysed as a potential marker of recall bias
but its inclusion did not meaningfully change the magni-
tude of the estimates and was not considered in the mul-
tiple linear regression models as covariate. In addition, the
validity of self-reported information on previous medical
diagnoses was not optimal. Accurate reporting of osteo-
arthritis medical labelling is dependent on the characteris-
tics of patients as well as on the medical workup used
(clinical evaluation and/or radiography). Previous studies
have shown that self-reported diagnosis of this type of
condition is not commonly congruent with the medical
one [41]. In our study, we found that agreement between
self-reported and clinical and radiographic osteoarthritis
diagnosis in our sample was poor (data not shown). How-
ever, independently of the accuracy of self-reported osteo-
arthritis (our main exposure), our priority was to assess
the beliefs of individuals regarding a potential presence of
osteoarthritis, whether it was clinically valid or not.
The identification of subjects with osteoarthritis was
based on a structured questionnaire where individuals
were asked about joint pain: individuals that did not re-
port joint pain were classified as not having osteoarthritis.
We assumed that questions about joint pain presence had
a negative predictive value of 100%. Although most osteo-
arthritis patients have joint pain [42], we recognize the
possibility of occurrence of false negatives. Additionally,
alternative diagnoses of the most common inflammatory
joint conditions were inquired (rheumatoid arthritis, anky-
losing spondylitis, psoriatic arthritis and systemic lupus
erythematosus). As expected, given their epidemiological
pattern, the frequency of those diseases was much lower
than that of osteoarthritis (below 2%). Thus, we do not ex-
pect that these contribute substantially to osteoarthritis
misclassification in this community-based sample.
Data on potential confounders of the associations be-
tween osteoarthritis medical labelling and health-related
quality of life were measured and included as covariates
in the multiple linear regression models (sex and age,
body mass index, clinical comorbidities – wide spectrum
of chronic diseases – and intensity of pain). Since these
variables returned significant changes in the magnitude
of the estimates and were statistically significant, they
remained in the models as confounders. Intensity of pain
episodes in the preceding month was used as proxy of
osteoarthritis severity. We understand that using diaries
of pain in which participants should report the intensity
Lourenço et al. Health and Quality of Life Outcomes 2014, 12:146 Page 8 of 9
http://www.hqlo.com/content/12/1/146of pain in loco was probably the most adequate approach
to measure the intensity of retrospective episodes of pain
and consequent severity of the disease. However, since
previous literature has shown that subjects are able to ac-
curately recall and rate severity of pain or discomfort and
that retrospective reports of intensity of pain are suffi-
ciently reliable [43], we believe that our methodological
option did not substantially change our main findings.
In addition, both osteoarthritis labelling and health-
related quality of life may be influenced by exposure to
joint pain treatments [11]. Nevertheless, we did not find
any significant difference between exposed and not ex-
posed individuals to osteoarthritis treatments (painkillers
and anti-inflammatory drugs, physiotherapy or thermal
spa) regarding the physical and mental health-related
quality of life scores, independently of the joint in study.
Osteoarthritis presence was clinically evaluated in three
different joints: knee, hip and hand. Concomitant osteo-
arthritis in the remaining sites may confound the associa-
tions between labelling in a specific site and quality of life:
a subject may be included in the analysis as exposed to
labelling regarding one joint and not exposed for the
remaining joints. A sensitivity analysis was conducted, by
stratifying the estimates according to the number of joints
affected. Since changes in the magnitude or direction of
associations were not observed, we believe that the num-
ber of joints diagnosed with osteoarthritis was not a major
drawback to the interpretation of our results.
Finally, the small sample sizes used in the linear regres-
sion models may be a methodological limitation, especially
when the models were computed using data only from in-
dividuals with clinically confirmed osteoarthritis. Sensitiv-
ity analyses were performed in order to test the impact in
our estimates of the small sample size using the bootstrap
method (replications = 100) [44]. We observed a remark-
able similarity between the 95% confidence intervals ob-
tained in the original analyses and those computed by
bootstrapping, which suggests that the small numbers of
participants that were used in the linear regression models
did not significantly impair our findings.
Conclusions
The labelling of knee, hip and hand osteoarthritis diagno-
sis may not add specific benefit to osteoarthritis patients
in terms of its capability to improve health-related quality
of life. Our findings may question the usefulness of active
case-finding of osteoarthritis during regular contacts of
asymptomatic individuals with the health care services.
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